Next Generation News and Research

RSS

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb® technology platform.

25 Aug 2014

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

The Perelman School of Medicine at the University of Pennsylvania has launched the Penn Center for Advanced Retinal and Ocular Therapeutics (CAROT) to build on its previous success developing novel therapies for the personalized diagnosis and treatment of retinal and ocular disorders.

22 Aug 2014

DNA testing for congenital cataracts can accurately diagnose diseases linked to childhood blindness

Researchers in the United Kingdom have demonstrated that advanced DNA testing for congenital cataracts can quickly and accurately diagnose a number of rare diseases marked by childhood blindness, according to a study published online today in Ophthalmology, the journal of the American Academy of Ophthalmology.

22 Aug 2014

IMRIS receives licensing to incorporate MRI core technology into VISIUS Surgical Theatre in Canada

IMRIS Inc. today announced that the Company has received Health Canada licensing to incorporate next generation MRI core technology into the VISIUS Surgical Theatre for sales and marketing in the country.

22 Aug 2014

Deep sequencing technique opens up new possibilities for finding genetic causes for brain disorder

Not every cell in the body is the same genetically, and disease-causing mutations don't necessarily affect every cell—making these mutations easy to miss even with next-generation genomic sequencing.

21 Aug 2014

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

The most common form of diabetes is sometimes referred to as metabolic diabetes, which is the diabetes most people are very familiar with, type 2 diabetes. This form of diabetes is most prevalent in people that are overweight or obese. Historically, it has been confined to adults or older patients but it has been on the rise as the global obesity problem has continued to worsen.

20 Aug 2014

Actavis reports positive results from ceftazidime-avibactam Phase III studies in cIAI patients

Actavis plc today confirmed positive topline results from RECLAIM-1 and -2, pivotal Phase III studies evaluating the potential for the investigational antibiotic, ceftazidime-avibactam as a treatment for adult hospitalized patients with complicated intra-abdominal infections.

19 Aug 2014

BGRF scientists propose Oncofinder method for accurate analysis of gene expression data

Scientists from the Biogerontology Research Foundation (BGRF), a UK-based charity founded to support ageing research and address the challenges of a rapidly ageing population, propose a new concept for signalome-wide analysis of changes in intracellular pathways, called OncoFinder, which allows for accurate and robust cross-platform analysis of gene expression data.

19 Aug 2014

NIH challenges innovators to compete for prizes by developing new ways to track a single cell

The National Institutes of Health is challenging science innovators to compete for prizes totaling up to $500,000, by developing new ways to track the health status of a single cell in complex tissue over time.

16 Aug 2014

HCN to acquire HealthLease REIT and 17 of Mainstreet's Next Generation properties

The nation's largest post-acute health care developer and one of the world's largest health care real estate companies have agreed to join forces to lead the evolution of post-acute care, an emerging solution in the changing health care landscape.

13 Aug 2014

Discovery of new mechanism could lead to next generation of drugs to treat schizophrenia

Discovery of a new mechanism of drug action could lead to the next generation of drugs to treat schizophrenia.

12 Aug 2014

TAXIS acquires novel antimicrobial drug candidates from Biota

TAXIS Pharmaceuticals, Inc. today announced the acquisition of a group of novel antimicrobial drug candidates from Biota Pharmaceuticals Inc. of Atlanta, GA.

11 Aug 2014

SCILEX completes patient enrollment to study Ztlido for treatment of postherpetic neuralgia

SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of late-stage pharmaceutical products focused on the treatment of pain, announced today that it has completed patient enrollment for the dermal safety studies and the pivotal pharmacokinetic study related to its investigational product Ztlido (lidocaine patch 1.8%), a next-generation branded lidocaine patch for the treatment of postherpetic neuralgia, also referred to as "after-shingles pain."

11 Aug 2014

Tumor genetic analysis reveals new approach of classifying cancers

Researchers with The Cancer Genome Atlas (TCGA) Research Network have completed the largest, most diverse tumor genetic analysis ever conducted, revealing a new approach to classifying cancers.

8 Aug 2014

Akron collaborates with Vivex Biomedical on use of next-generation line of cryopreservation media

Akron is pleased to announce that it secured a strategic collaboration with Vivex Biomedical, Inc. on the use of its next-generation line of cryopreservation media, CryoNovo™.

7 Aug 2014

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today results demonstrating the improved immunogenicity and rapid action of its anthrax vaccine, VeloThrax™.

7 Aug 2014

Ability Dynamics announces new exclusive distribution relationship with OPC Health

Ability Dynamics, LLC an innovative developer of next-generation prosthetic devices announced a new exclusive distribution relationship with Australian based OPC Health for its flagship products the RUSH™ HiPro and the RUSH™LoPro prosthetic feet.

5 Aug 2014

Engineers create truly portable device for nuclear magnetic resonance spectroscopy

A team of engineers at the Harvard School of Engineering and Applied Sciences (SEAS), Schlumberger-Doll Research Center in Cambridge, Mass., and the University of Texas, Austin, have created a truly portable device for nuclear magnetic resonance (NMR) spectroscopy.

5 Aug 2014

Clinical trial to look for genetic information in cancer patients

Sanford Health is working to enroll approximately 50 adult patients whose cancer has progressed after the first line of treatment or who have rare cancers without standard treatment options in a clinical trial to look for genetic information that could help customize treatment options.

4 Aug 2014

New web-based tool enables researchers to quickly visualize genomic information

Scientists at the University of Maryland have developed a new, web-based tool that enables researchers to quickly and easily visualize and compare large amounts of genomic information resulting from high-throughput sequencing experiments.

4 Aug 2014

Next Generation News and Research

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

DNA testing for congenital cataracts can accurately diagnose diseases linked to childhood blindness

IMRIS receives licensing to incorporate MRI core technology into VISIUS Surgical Theatre in Canada

Deep sequencing technique opens up new possibilities for finding genetic causes for brain disorder

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

Actavis reports positive results from ceftazidime-avibactam Phase III studies in cIAI patients

BGRF scientists propose Oncofinder method for accurate analysis of gene expression data

NIH challenges innovators to compete for prizes by developing new ways to track a single cell

HCN to acquire HealthLease REIT and 17 of Mainstreet's Next Generation properties

Discovery of new mechanism could lead to next generation of drugs to treat schizophrenia

TAXIS acquires novel antimicrobial drug candidates from Biota

SCILEX completes patient enrollment to study Ztlido for treatment of postherpetic neuralgia

Tumor genetic analysis reveals new approach of classifying cancers

Akron collaborates with Vivex Biomedical on use of next-generation line of cryopreservation media

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Ability Dynamics announces new exclusive distribution relationship with OPC Health

Engineers create truly portable device for nuclear magnetic resonance spectroscopy

Clinical trial to look for genetic information in cancer patients

New web-based tool enables researchers to quickly visualize genomic information

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News